Spectrum Pharmaceuticals, Inc. Highlights 13 Abstracts At The 55th Annual Meeting Of The American Society of Hematology, New Orleans, Louisiana, December 7-10, 2013

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced key presentations of clinical and scientific data at the 55th Annual Meeting of the American Society of Hematology (ASH), being held in New Orleans, Louisiana, from December 7-10, 2013.

Help employers find you! Check out all the jobs and post your resume.